Skip to main content
An official website of the United States government

anti-FLT-1 ribozyme

A nuclease-stabilized synthetic ribozyme (ribonucleic acid enzyme) with potential anti-angiogenesis activity. Ribozyme RPI.4610 specifically recognizes the mRNA for FLT1 (vascular endothelial growth factor receptor 1; VEGFR1), and hydrolyzes the mRNA, thereby preventing VEGFR1 proteins from being made. This may prevent VEGF-stimulated angiogenesis in cancerous tissue and metastasis.
Check for active clinical trials using this agentView this agent in the NCI Thesaurus
US brand name:Angiozyme
Foreign brand name:Angiozyme
Code name:RPI.4610
Search NCI's Drug Dictionary
Please enter up to 30 characters for your search